Psyence Biomedical Ltd. (PBMWW) stock

PBMWWNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBM

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 22, 2026Score 0/30

$0.01−0.00 (-2.50%)

Close on Oct 30, 2026Market cap –P/E –Yield –

Psyence Biomedical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Psyence Biomedical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.